Millions of people who live with chronic pain hear some version of the same dismissal: the scan looks fine, so the problem must be in your head. Neuroscience has spent the last two decades proving that statement is both partly right and deeply misleading. The problem is in the head, but not in the way skeptics mean. Measurable changes in the brain and spinal cord can amplify pain signals and keep them firing long after injured tissue has healed. As of May 2026, the evidence base for these mechanisms is large enough that major health authorities recognize chronic pain as a disorder of neural processing, not a failure of character.
Central sensitization: when the volume knob gets stuck
The most established explanation for persistent pain centers on a process called central sensitization. Nerve circuits in the spinal cord and brain can increase their responsiveness to incoming pain signals through synaptic plasticity, the same connection-strengthening mechanism that underlies learning and memory. Once those circuits are sensitized, two well-documented problems follow. The first, hyperalgesia, means a mildly painful stimulus feels far worse than it should. The second, allodynia, means a completely harmless touch, like a light brush across the skin, registers as painful.
A widely cited review in the journal PAIN details how specific central nervous system pathways can amplify pain and become the primary driver of symptoms even after the original injury site has recovered. The key insight is that the pain is not being generated at the wound. It is being generated, or at minimum sustained, by the nervous system itself.
“Central sensitization is not a fringe idea anymore. It is the mainstream explanation for why pain outlasts injury in so many patients,” said Clifford Woolf, a neurobiologist at Harvard Medical School who first described the mechanism in the early 1980s. Woolf’s original work demonstrated that spinal cord neurons could be driven into a hyperexcitable state by repeated nociceptive input, a finding that has since been replicated across dozens of laboratories worldwide.
The brain rewires itself as pain becomes chronic
Longitudinal neuroimaging studies, which track the same patients over months or years, have added a second layer of proof. A 2012 study published in Nature Neuroscience by A. Vania Apkarian and colleagues at Northwestern University followed patients with subacute back pain and found that connectivity patterns between the prefrontal cortex and the nucleus accumbens, a structure embedded in the brain’s reward circuitry, could predict which patients’ pain would persist over the following year. The severity of the original back injury did not predict the outcome. The brain’s wiring did.
A related study published in the journal Brain documented what happens inside the brain as back pain transitions from a new problem to a chronic one. Neural activity gradually shifts away from classical sensory pain-processing regions and toward limbic and emotional circuits. In plain terms, the brain stops treating chronic pain primarily as a sensory alarm and begins processing it more like an emotional state. That shift helps explain a pattern clinicians see constantly: chronic pain traveling alongside anxiety and depression, not because patients are emotionally fragile, but because the same brain circuits are involved.
Beyond back pain: nociplastic pain gets official recognition
These findings extend well beyond sore backs. In 2017, the International Association for the Study of Pain (IASP) formally adopted the term “nociplastic pain” as a third mechanistic category alongside nociceptive pain (caused by tissue damage) and neuropathic pain (caused by nerve injury). Nociplastic pain arises from altered processing within the central nervous system itself, without clear evidence of tissue or nerve damage driving the signals.
Conditions that fall under this umbrella include fibromyalgia, irritable bowel syndrome, and many cases of chronic low back pain. The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, recognizes nociplastic pain in its public information on pain conditions, confirming that federal health authorities accept the category as legitimate. For patients who have been told “we can’t find anything wrong,” the recognition matters. Something is wrong. It is happening in the central nervous system rather than at the site where the pain is felt.
What researchers are still working out
The basic science is strong, but several important questions remain open.
Limited conditions studied longitudinally. Most of the brain-imaging work that tracks patients over time has focused on back pain. Whether the same corticostriatal connectivity patterns predict chronification in fibromyalgia, irritable bowel syndrome, or other nociplastic conditions has not been established with comparable longitudinal data. Researchers suspect similar emotional-circuit shifts occur across pain types, but direct imaging evidence for non-back conditions is thinner.
No proven way to intercept chronification early. If emotional and reward circuits drive the transition to chronic pain, then interventions targeting those circuits, such as cognitive-behavioral therapy, graded exposure, or neuromodulation, could theoretically interrupt the process before it locks in. That hypothesis is biologically plausible and consistent with the imaging data. But no large-scale randomized trial has yet demonstrated that modulating early limbic brain shifts prevents pain from becoming chronic.
Individual vulnerability is poorly understood. Not everyone with an acute injury develops chronic pain, even when the injuries look identical on imaging. Genetic factors, early life stress, mood disorders, and social context have all been proposed as contributors. The relative weight of each factor remains unclear, and long-term cohort studies combining brain imaging, psychological assessment, and genetic data are still limited in number.
The opioid connection is logical but unproven. Because sensitized circuits amplify pain, patients may seek escalating medication doses that target peripheral signals without correcting the central problem. The mechanistic logic is sound, and clinicians report this pattern, but controlled data directly linking central sensitization to opioid escalation or misuse have not been published in the primary literature. The connection remains an inference, not a confirmed finding.
What patients can say and what treatments show the most promise
For patients, the practical message from this body of research is straightforward. Pain that persists after an injury heals is not a sign of weakness, exaggeration, or fabrication. It reflects measurable changes in how the central nervous system processes signals, changes visible on brain scans and reproducible across studies.
That understanding should shape how patients talk to their doctors. Daniel Clauw, a rheumatologist and chronic pain researcher at the University of Michigan, has recommended that patients use specific language when they feel dismissed: “Tell your provider that you’d like to be evaluated for central sensitization or nociplastic pain, and ask whether they are familiar with those terms. If they are not, that is useful information about whether you are in the right clinic.” Framing the conversation around recognized medical terminology can shift the dynamic from “prove your pain is real” to “help me find the right treatment.”
As of spring 2026, the treatments with the strongest evidence for nociplastic pain conditions include cognitive-behavioral therapy (CBT), which has shown consistent moderate effects across multiple systematic reviews; graded exercise therapy, which helps recalibrate the nervous system’s threat response; and dual-mechanism medications such as duloxetine and milnacipran, which act on descending pain-inhibition pathways in the spinal cord rather than at the injury site. Newer approaches under active investigation include transcranial magnetic stimulation and pain reprocessing therapy, though large-scale confirmatory trials for both are still underway.
The science is still evolving. Researchers have not yet pinpointed how to prevent acute pain from becoming chronic, and the best combination of therapies for established nociplastic pain is an active area of investigation. But the core finding is no longer in dispute. Chronic pain is a disorder of neural processing, grounded in biology, and it deserves the same seriousness as any other long-term medical condition. The brain pathways are real. The suffering they produce is, too.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
